LT3737684T - 2,4,6,7-tetrahidro-pirazolo[4,3-d]pirimidin-5-ono dariniai ir susiję junginiai, kaip c5a receptoriaus moduliatoriai, skirti vaskulito ir uždegiminių ligų gydymui - Google Patents
2,4,6,7-tetrahidro-pirazolo[4,3-d]pirimidin-5-ono dariniai ir susiję junginiai, kaip c5a receptoriaus moduliatoriai, skirti vaskulito ir uždegiminių ligų gydymuiInfo
- Publication number
- LT3737684T LT3737684T LTEPPCT/EP2019/050372T LTEP2019050372T LT3737684T LT 3737684 T LT3737684 T LT 3737684T LT EP2019050372 T LTEP2019050372 T LT EP2019050372T LT 3737684 T LT3737684 T LT 3737684T
- Authority
- LT
- Lithuania
- Prior art keywords
- pyrazolo
- vasculitis
- pyrimidin
- tetrahydro
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Eye Examination Apparatus (AREA)
- Oscillators With Electromechanical Resonators (AREA)
- Heat Sensitive Colour Forming Recording (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP2018050598 | 2018-01-10 | ||
| PCT/EP2019/050372 WO2019137927A1 (en) | 2018-01-10 | 2019-01-09 | 2,4,6,7-tetrahydro-pyrazolo[4,3-d]pyrimidin-5-one derivatives and related compounds as c5a receptor modulators for treating vasculitis and inflammatory diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LT3737684T true LT3737684T (lt) | 2022-12-27 |
Family
ID=65012016
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTEPPCT/EP2019/050372T LT3737684T (lt) | 2018-01-10 | 2019-01-09 | 2,4,6,7-tetrahidro-pirazolo[4,3-d]pirimidin-5-ono dariniai ir susiję junginiai, kaip c5a receptoriaus moduliatoriai, skirti vaskulito ir uždegiminių ligų gydymui |
Country Status (30)
| Country | Link |
|---|---|
| US (2) | US11608341B2 (lt) |
| EP (1) | EP3737684B1 (lt) |
| JP (1) | JP7014914B2 (lt) |
| KR (1) | KR102574564B1 (lt) |
| CN (1) | CN111566109B (lt) |
| AR (1) | AR114564A1 (lt) |
| AU (1) | AU2019207666B2 (lt) |
| BR (1) | BR112020013788A2 (lt) |
| CA (1) | CA3086310C (lt) |
| CL (1) | CL2020001817A1 (lt) |
| DK (1) | DK3737684T3 (lt) |
| EA (1) | EA202091641A1 (lt) |
| ES (1) | ES2933820T3 (lt) |
| HR (1) | HRP20221449T1 (lt) |
| HU (1) | HUE060515T2 (lt) |
| IL (1) | IL275868B2 (lt) |
| LT (1) | LT3737684T (lt) |
| MA (1) | MA51558B1 (lt) |
| MX (1) | MX2020007443A (lt) |
| MY (1) | MY198902A (lt) |
| PH (1) | PH12020500583B1 (lt) |
| PL (1) | PL3737684T3 (lt) |
| PT (1) | PT3737684T (lt) |
| RS (1) | RS63806B1 (lt) |
| SG (1) | SG11202006490YA (lt) |
| SI (1) | SI3737684T1 (lt) |
| TW (2) | TWI774905B (lt) |
| UA (1) | UA124694C2 (lt) |
| WO (1) | WO2019137927A1 (lt) |
| ZA (1) | ZA202004910B (lt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3737684B1 (en) * | 2018-01-10 | 2022-11-16 | Idorsia Pharmaceuticals Ltd | 2,4,6,7-tetrahydro-pyrazolo[4,3-d]pyrimidin-5-one derivatives and related compounds as c5a receptor modulators for treating vasculitis and inflammatory diseases |
| CA3087886A1 (en) | 2018-01-19 | 2019-07-25 | Idorsia Pharmaceuticals Ltd | C5a receptor modulators |
| CN111683937A (zh) * | 2018-01-19 | 2020-09-18 | 爱杜西亚药品有限公司 | C5a受体调节剂 |
| JP2022540780A (ja) * | 2019-07-09 | 2022-09-20 | イドーシア ファーマシューティカルズ リミテッド | テトラヒドロピラゾロピリミジノン化合物を含有する医薬組成物 |
| US11193891B2 (en) * | 2019-12-20 | 2021-12-07 | Robert Bosch Gmbh | Receptors and spacers for a fluorescence-based lead ion chemosensor |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1487798A4 (en) * | 2002-03-28 | 2005-07-13 | Neurogen Corp | Substituted tetrahydroisoquinolines as C5A receptor modulators |
| WO2004033455A2 (en) * | 2002-10-08 | 2004-04-22 | Novo Nordisk A/S | Hemisuccinate salts of heterocyclic dpp-iv inhibitors |
| WO2006042102A2 (en) * | 2004-10-05 | 2006-04-20 | Neurogen Corporation | Pyrrolo-pyridine, pyrrolo-pyrimidine and related heterocyclic compounds |
| HUE033644T2 (en) * | 2010-06-24 | 2017-12-28 | Chemocentryx Inc | C5AR antagonists |
| US8846656B2 (en) * | 2011-07-22 | 2014-09-30 | Novartis Ag | Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as C5a receptor modulators |
| TWI736135B (zh) * | 2013-03-01 | 2021-08-11 | 美商英塞特控股公司 | 吡唑并嘧啶衍生物治療PI3Kδ相關病症之用途 |
| WO2015034820A1 (en) | 2013-09-04 | 2015-03-12 | Bristol-Myers Squibb Company | Compounds useful as immunomodulators |
| SG11201601682RA (en) | 2013-09-06 | 2016-04-28 | Aurigene Discovery Tech Ltd | 1,2,4-oxadiazole derivatives as immunomodulators |
| WO2015044900A1 (en) | 2013-09-27 | 2015-04-02 | Aurigene Discovery Technologies Limited | Therapeutic immunomodulating compounds |
| ES2835717T3 (es) * | 2014-09-16 | 2021-06-23 | Gilead Sciences Inc | Formas sólidas de un modulador de receptor de tipo Toll |
| US9682940B2 (en) * | 2015-08-25 | 2017-06-20 | Janssen Pharmaceutica Nv | Indazole derivatives useful as CB-1 inverse agonists |
| EP3737684B1 (en) * | 2018-01-10 | 2022-11-16 | Idorsia Pharmaceuticals Ltd | 2,4,6,7-tetrahydro-pyrazolo[4,3-d]pyrimidin-5-one derivatives and related compounds as c5a receptor modulators for treating vasculitis and inflammatory diseases |
| CN111683937A (zh) | 2018-01-19 | 2020-09-18 | 爱杜西亚药品有限公司 | C5a受体调节剂 |
| CA3087886A1 (en) | 2018-01-19 | 2019-07-25 | Idorsia Pharmaceuticals Ltd | C5a receptor modulators |
| JP2022540780A (ja) | 2019-07-09 | 2022-09-20 | イドーシア ファーマシューティカルズ リミテッド | テトラヒドロピラゾロピリミジノン化合物を含有する医薬組成物 |
-
2019
- 2019-01-09 EP EP19700269.4A patent/EP3737684B1/en active Active
- 2019-01-09 MX MX2020007443A patent/MX2020007443A/es unknown
- 2019-01-09 CA CA3086310A patent/CA3086310C/en active Active
- 2019-01-09 EA EA202091641A patent/EA202091641A1/ru unknown
- 2019-01-09 MY MYPI2020003550A patent/MY198902A/en unknown
- 2019-01-09 MA MA51558A patent/MA51558B1/fr unknown
- 2019-01-09 LT LTEPPCT/EP2019/050372T patent/LT3737684T/lt unknown
- 2019-01-09 WO PCT/EP2019/050372 patent/WO2019137927A1/en not_active Ceased
- 2019-01-09 ES ES19700269T patent/ES2933820T3/es active Active
- 2019-01-09 JP JP2020538035A patent/JP7014914B2/ja active Active
- 2019-01-09 TW TW108100804A patent/TWI774905B/zh active
- 2019-01-09 US US16/961,600 patent/US11608341B2/en active Active
- 2019-01-09 HU HUE19700269A patent/HUE060515T2/hu unknown
- 2019-01-09 CN CN201980007596.9A patent/CN111566109B/zh active Active
- 2019-01-09 SI SI201930400T patent/SI3737684T1/sl unknown
- 2019-01-09 HR HRP20221449TT patent/HRP20221449T1/hr unknown
- 2019-01-09 PL PL19700269.4T patent/PL3737684T3/pl unknown
- 2019-01-09 DK DK19700269.4T patent/DK3737684T3/da active
- 2019-01-09 PH PH1/2020/500583A patent/PH12020500583B1/en unknown
- 2019-01-09 UA UAA202004963A patent/UA124694C2/uk unknown
- 2019-01-09 AU AU2019207666A patent/AU2019207666B2/en active Active
- 2019-01-09 AR ARP190100043A patent/AR114564A1/es unknown
- 2019-01-09 SG SG11202006490YA patent/SG11202006490YA/en unknown
- 2019-01-09 KR KR1020207022343A patent/KR102574564B1/ko active Active
- 2019-01-09 BR BR112020013788-0A patent/BR112020013788A2/pt unknown
- 2019-01-09 TW TW111127843A patent/TWI839788B/zh active
- 2019-01-09 RS RS20221138A patent/RS63806B1/sr unknown
- 2019-01-09 PT PT197002694T patent/PT3737684T/pt unknown
-
2020
- 2020-07-06 IL IL275868A patent/IL275868B2/en unknown
- 2020-07-08 CL CL2020001817A patent/CL2020001817A1/es unknown
- 2020-08-07 ZA ZA2020/04910A patent/ZA202004910B/en unknown
-
2022
- 2022-12-20 US US18/084,911 patent/US20230192708A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LT3737684T (lt) | 2,4,6,7-tetrahidro-pirazolo[4,3-d]pirimidin-5-ono dariniai ir susiję junginiai, kaip c5a receptoriaus moduliatoriai, skirti vaskulito ir uždegiminių ligų gydymui | |
| PL3873900T3 (pl) | Imidazo[1,2-a]pirydynowe pochodne jako inhibitory integryny alpha4beta7 do leczenia chorób zapalnych | |
| LT3697784T (lt) | Imidazo[4,5-b]piridino junginiai ir jų farmacinės kompozicijos, skirtos uždegiminių sutrikimų gydymui | |
| HUE064667T2 (hu) | Pirido[3',4':4,5]pirrolo[1,2,3-de]kinoxalin származékok központi idegrendszeri betegségek kezelésében történõ alkalmazásra | |
| HUE057549T2 (hu) | Imidazo[1,2-a]pirimidinszármazékok, eljárás elõállításukra és alkalmazásaik | |
| IL268850A (en) | Combinations of a 4-pyrimidinesulfamide derivative with active ingredients for the treatment of endothelin related diseases | |
| EP3107914B8 (en) | Pyrazolo[1,5-a]pyrimidine-5,7-diamine compounds as cdk inhibitors and their therapeutic use | |
| SG11201907095UA (en) | DERIVATIVES OF N-CYCLOALKYL/HETEROCYCLOALKYL-4-(IMIDAZO [1,2-a]PYRIDINE)PYRIMIDIN-2-AMINE AS THERAPEUTIC AGENTS | |
| DK3177627T3 (da) | Imidazo[1,2-a]-pyrazolo[4,3-e]-pyrimidin-4-on-derivater med pde1-hæmmende aktivitet | |
| IL268357A (en) | Photoreceptor cells for the treatment of retinal diseases | |
| EP3709998B8 (en) | N-[5-(imidazo[1,2-a]pyrimidin-2-yl)phenyl]-benzamide and -benzeneacetamide derivatives as tnf stimulators for the treatment of e.g. infectious diseases and cancer | |
| IL264603A (en) | Reelin compositions for treatment of neurological disorders | |
| HRP20180788T1 (hr) | [1,2,4]triazolo[4,3-b]piridazini za uporabu za liječenje proliferativnih bolesti | |
| IL270927B (en) | 5,6-fused-bicyclic compounds and compositions for the treatment of parasitic diseases | |
| PL3597648T3 (pl) | METODA WYTWARZANIA 3,6-DIPODSTAWIONEJ POCHODNEJ IMIDAZO[1, 2-b]PIRYDAZYNY | |
| HUE047822T2 (hu) | Immun- vagy gyulladásos betegségek és rák kezelésére alkalmas 7-(morfolin-4-il)pirazol[1,5-a]pirimidin-származékok | |
| EP3854401A4 (en) | PURINE DERIVATIVES CDC7 INHIBITORS AND THEIR USE FOR THE TREATMENT OF NEUROLOGICAL PATHOLOGIES | |
| ZA201902828B (en) | Crystal of pyrido[3, 4-d]pyrimidine derivative or solvate thereof | |
| EP3509543A4 (en) | ACTIVE SUBSTANCE RELEASING SPACER FOR JOINTS OF THE HUMAN BODY | |
| EP3634395A4 (en) | LIXIVAPTAN FORMULATIONS FOR THE TREATMENT OF POLYKYSTOSIS | |
| HK40040026A (en) | Heterocyclic compounds useful in the treatment of disease | |
| IL253427A0 (en) | The result of pyrazolo[3,4-d]pyrimidine and its use in the treatment of Jericho rose | |
| HK40007136A (en) | Fused bicyclic compounds for the treatment of disease |